Nothing Special   »   [go: up one dir, main page]

Belenguer et al., 2013 - Google Patents

The dynamin GTPase OPA1: more than mitochondria?

Belenguer et al., 2013

View HTML
Document ID
10856300812404776116
Author
Belenguer P
Pellegrini L
Publication year
Publication venue
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research

External Links

Snippet

The studies addressing the molecular mechanisms governing mitochondrial fusion and fission have brought to light a small group of dynamin-like GTPases (Guanosine- Triphosphate hydrolase) as central regulators of mitochondrial morphology and cristae …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Similar Documents

Publication Publication Date Title
Belenguer et al. The dynamin GTPase OPA1: more than mitochondria?
Bertholet et al. Mitochondrial fusion/fission dynamics in neurodegeneration and neuronal plasticity
Chandhok et al. Structure, function, and regulation of mitofusin‐2 in health and disease
Reddy et al. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases
Adaniya et al. Posttranslational modifications of mitochondrial fission and fusion proteins in cardiac physiology and pathophysiology
MacVicar et al. OPA1 processing in cell death and disease–the long and short of it
Bamburg Proteins of the ADF/cofilin family: essential regulators of actin dynamics
Kandimalla et al. Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis
Flippo et al. Mitochondrial dynamics in neuronal injury, development and plasticity
Cho et al. Mitochondrial dynamics in cell death and neurodegeneration
Marín-García et al. Mitochondrial dynamics and cell death in heart failure
Ben Zablah et al. The role of ADF/cofilin in synaptic physiology and Alzheimer’s disease
Cummins et al. Shedding light on mitophagy in neurons: what is the evidence for PINK1/Parkin mitophagy in vivo?
De Brito et al. Mitofusin 2: a mitochondria-shaping protein with signaling roles beyond fusion
Tedesco et al. Insights on human small heat shock proteins and their alterations in diseases
Landes et al. OPA1 (dys) functions
Petkovic et al. Interorganelle communication, aging, and neurodegeneration
Sandri New findings of lysosomal proteolysis in skeletal muscle
Cardinale et al. Biochemical characterization of sirtuin 6 in the brain and its involvement in oxidative stress response
M Wilson et al. The implications of sortilin/vps10p domain receptors in neurological and human diseases
Inestrosa et al. Acetylcholinesterase (AChE)-amyloid-β-peptide complexes in Alzheimer's disease. The Wnt signaling pathway
AU2013311714B2 (en) Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases
Jackson et al. Mitochondrial diseases caused by dysfunctional mitochondrial protein import
Patrushev et al. Mitochondrial fission and fusion
Deutsch et al. Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications